Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells
Circulation · 15.04.2025 · 151 (15) · 1076-1094
DOI: 10.1161/circulationaha.124.070217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 15.04.2025. Verfasst von Cholomi Jung und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (C.J., E.J.L.), Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Se…. Hauptthemen laut MEDLINE: Myocytes, Smooth Muscle, Fibroblasts, Cellular Reprogramming, Ischemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Although cell therapy has emerged as a promising approach to promote neovascularization, its effects are mostly limited to capillaries. To generate larger or more stable vessels, layering of mural cells such as smooth muscle cells (SMCs) or pericytes is required. Recently, direct reprogramming approaches have been developed for generating SMCs. However, such reprogrammed SMCs lack genuine features of contractile SMCs, a native SMC phenotype; thus, their therapeutic and vessel-forming potential in vivo was not explored. Therefore, we aimed to directly reprogram human dermal fibroblasts toward contractile SMCs (rSMCs) and investigated their role for generating vascular mural cells in vivo and their therapeutic effects on ischemic disease. METHODS: We applied myocardin and all- trans retinoic acid with specific culture conditions to directly reprogram human dermal fibroblasts into rSMCs. We characterized their phenotype as contractile SMCs through quantitative reverse-transcriptase polymerase chain reaction, flow cytometry, and immunostaining. We then explored their contractility using a vasoconstrictor, carbachol, and through transmission electron microscope and bulk RNA sequencing. Next, we evaluated whether transplantation of rSMCs improves blood flow and induces vessel formation as mural cells in a mouse model of hindlimb ischemia with laser Doppler perfusion imaging and histological analysis. We also determined their paracrine effects. RESULTS: Our novel culture conditions using myocardin and all- trans retinoic acid efficiently reprogrammed human dermal fibroblasts into SMCs. These rSMCs displayed characteristics of contractile SMCs at the mRNA, protein, and cellular levels. Transplantation of rSMCs into ischemic mouse hind limbs enhanced blood flow recovery and vascular repair and improved limb salvage. Histological examination showed that vascular density was increased and the engrafted rSMCs were incorporated into the vascular wall as pericytes and vascular SMCs, thereby contributing to formation of more stable and larger microvessels. Quantitative reverse-transcriptase polymerase chain reaction analysis revealed that these transplanted rSMCs exerted pleiotropic effects, including angiogenic, arteriogenic, vessel-stabilizing, and tissue regenerative effects, on ischemic limbs. CONCLUSIONS: A combination of myocardin and all- trans retinoic acid in defined culture conditions efficiently reprogrammed human fibroblasts into contractile and functional SMCs. The rSMCs were shown to be effective for vascular repair and contributed to neovascularization through mural cells and various paracrine effects. These human rSMCs could represent a novel source for cell-based therapy and research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine (C.J., E.J.L.), Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Severance Biomedical Science Institute (C.J., S.-J.L., J.E.O., S.K., C.D., J.K., Y.-s.Y.), Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA (J.W.H., K.H.K., S.B., S.L., N.C., Y.-s.Y).
- Department of Medicine, Division of Cardiovascular Medicine, Department of Cell and Developmental Biology, and Vanderbilt Center for Stem Cell Biology, Vanderbilt University, Nashville, TN (Y.-J.N.).
- Department of Biotechnology, Yonsei University, Seoul, Republic of Korea (C.D.).
- Department of Rehabilitation Medicine (J.K.), Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Seongho Bae, Sangho Lee, Sangsung Kim, Eun Jig Lee, Young-Sup Yoon
Förderung
- NHLBI NIH HHS
Zitieren
APA
Jung, C., Han, J. W., Lee, S. J., Kim, K. H., Oh, J. E., Bae, S., Lee, S., Nam, Y. J., Kim, S., Dang, C., Kim, J., Chu, N., Lee, E. J., & Yoon, Y. S. (2025). Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells. Circulation, 151(15), 1076-1094. https://doi.org/10.1161/circulationaha.124.070217
Vancouver
Jung C, Han JW, Lee SJ, Kim KH, Oh JE, Bae S, et al. Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells. Circulation. 2025;151(15):1076-1094. doi:10.1161/circulationaha.124.070217
BibTeX
@article{Jung2025,
author = {Jung, Cholomi and Han, Ji Woong and Lee, Shin-Jeong and Kim, Kyung Hee and Oh, Jee Eun and Bae, Seongho and Lee, Sangho and Nam, Young-Jae and Kim, Sangsung and Dang, Chaewon and Kim, Jaehyun and Chu, Nakhyung and Lee, Eun Jig and Yoon, Young-Sup},
title = {Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells},
journal = {Circulation},
year = {2025},
volume = {151},
number = {15},
pages = {1076--1094},
doi = {10.1161/circulationaha.124.070217}
}
EUVIMED